This site is intended for healthcare professionals
News

FDA approves Breyanzi to treat large B-cell lymphoma (including diffuse large B-cell lymphoma) after two or more lines of systemic therapy.- BMS

Read time: 1 mins
Last updated:9th Feb 2021
Published:9th Feb 2021
Condition: B Cell Lymphoma (NHL)
Type: drug
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest